STEINMAN LAWRENCE → Pasithea Therapeutics Corp. KTTAW

Stake: 3.10% Shares: 83,858 CUSIP: 70261F202 Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Passive Schedule 13G filer baseline
Moderate short days-to-cover (3.3 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-09-15

DTC 3.26

26,825 shares short · -1.5% vs prior

Post-Filing Returns · since 2025-03-01 on KTTAW

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 0.01 on closest trading day on/after 2025-03-01. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Pasithea Therapeutics Corp.

Filed	Form	Filer	Stake	Shares
2026-07-01	SCHEDULE 13G/A	Coastlands Capital LP	—	—	view →
2026-06-23	SCHEDULE 13G	Stonepine Capital Management, LLC	—	—	view →
2022-09-01	SC	Camac Fund, LP	—	—	view →
2022-06-27	SC	Camac Fund, LP	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →